Ascendis Pharma A (ASND) Other Non Operating Income (2014 - 2018)
Ascendis Pharma A's (ASND) quarterly Other Non Operating Income came in at -$4.9 million in Q4 2018, down 170.09% year-on-year from $7.0 million in Q4 2017, and down 170.09% quarter-over-quarter from -$1.8 million in Q4 2017.
Ascendis Pharma A (ASND) Other Non Operating Income (2014 - 2018) Analysis & Trends
Ascendis Pharma A has disclosed Other Non Operating Income across 5 years of filings, most recently posting -$4.9 million for Q4 2018.
- Other Non Operating Income for Q4 2018 came in at -$4.9 million, down 170.09% year-over-year; the trailing twelve-month figure through Dec 2018 was -$4.9 million (down 170.09% YoY), and the FY2018 annual result was -$4.9 million, down 170.09% from the prior year.
- Other Non Operating Income came in at -$4.9 million for Q4 2018 at Ascendis Pharma A, down from -$1.8 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.2 million in Q4 2016 to a low of -$4.9 million in Q4 2018.
- The 5-year median for Other Non Operating Income is $393506.1 (2015), against an average of -$931302.0.
- Across the five-year window, Other Non Operating Income soared 216.37% in 2016 and slumped 246.88% in 2017, its largest moves.
- Ascendis Pharma A's Other Non Operating Income stood at $472437.1 in 2014, then retreated by 16.71% to $393506.1 in 2015, then jumped by 216.37% to $1.2 million in 2016, then plunged by 246.88% to -$1.8 million in 2017, then sank by 170.09% to -$4.9 million in 2018.
- The last three Other Non Operating Income figures came in at -$4.9 million (Q4 2018), -$1.8 million (Q4 2017), and $1.2 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ascendis Pharma A | 2.75 Bn | 2.08 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -4.94 Mn |
| Dec 31, 2017 | -1.83 Mn |
| Dec 31, 2016 | 1.24 Mn |
| Dec 31, 2015 | 393,506.10 |
| Dec 31, 2014 | 472,437.06 |